Presentation

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Presenter: 127662|Luca Testa

February 27, 2013

REGISTER for free or LOG IN to view this content

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Aortic Valve

Factoid

Up Next

Presentation

Lack of Aspirin Prior to PCI Relatively Common and Strongly Associated with IncreasedIn-Hospital Mortality

Presenter: M. Kenaan

March 07, 2013

More slides +

Presentation

The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent with a PES

Presenter: Michael Haude

April 03, 2013

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Rebecca T. Hahn

October 15, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.